Grant: Discovery Grants Program - Individual
McGill University
$54,000.00
Regulation of skeletal muscle mass and function by long non-coding RNAs
EF 2024-25
Résumé
Rationale: Skeletal muscles play critical roles in locomotion and metabolism. Over the past 10 years, with support from the NSERC, I established a leading-edge program on autophagy (degradation and recycling of cellular components) in skeletal muscles. In this proposal, I will identify novel long non-coding RNAs (lncRNAs) that regulate skeletal muscle mass and function. LncRNAs (>200 nucleotides in length) are abundant, exert their functions through various mechanisms, and are implicated in many cellular processes. Little is known, however, about their roles in skeletal muscles. This project will identify lncRNAs and the molecular networks that regulate muscle homeostasis. To identify lncRNAs that regulate muscle atrophy, we performed pilot experiments in which adult mice were subjected to 24h of acute starvation or 7 days of hindlimb denervation. Transcriptome analyses of limb muscles revealed that only four upregulated (Gm16041, Gm45805, Gm15179, lnc-Trim63) and two downregulated (Gm3331, Gm28505) lncRNAs were consistently observed in both models of atrophy. In the next five years, I will identify the roles of these novel lncRNAs in the regulation of skeletal muscle homeostasis by achieving the following objectives:
Objective 1: To identify cellular and intracellular localization of lncRNAs in skeletal muscles. The six targeted lncRNAs will be detected by fluorescence in-situ hybridization and isolation of nuclear and cytoplasmic fractions of human and mouse skeletal muscles. Additionally, single muscle fibres will be isolated from mouse limb muscles and will be subjected to qPCR detection of lncRNAs.
Objective 2: To identify the roles of lncRNAs in skeletal muscle survival, proliferation, and differentiation. Gain-of- (overexpression) and loss-of-function (knockdown with GampeRs) approaches will be used to assess the roles of the six targeted lncRNA in the regulation of survival, proliferation, and differentiation of myoblasts (muscle progenitor cells) derived from humans and mice.
Objective 3: To identify the regulatory roles of lncRNAs in skeletal muscle and mass and function. Gain-of-function (overexpression) and loss-of-function (knockdown) of the six targeted lncRNAs in skeletal muscles of adult mice will be achieved by injecting adeno-associated viruses expressing full-length lncRNAs (overexpression) or anti-sense oligos (GapmeRs, knockdown) into limb muscles. Mice will be examined 4, 6, and 12 weeks later and muscles will be excised and examined for fibre size and type, mitochondrial function, proteolysis, and contractility using established assays.
Objective 4: To identify molecular mechanisms through which lncRNAs regulate skeletal muscle mass. Bulk RNA-Seq and metabolomic analyses will be performed on muscle samples in which the lncRNAs have been overexpressed or downregulated, as in Objective 3. Additionally, protein partners of a given lncRNA will be identified by RNA-pull down assays and mass spectrometry.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2024-04520
Name nom
Hussain, Sabah
Department département
Medicine
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
54000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Regulation of skeletal muscle mass and function by long non-coding RNAs
Keywords
skeletal muscles; non-coding rnas; long non-coding rnas; muscle atrophy; autophagy; rna-seq; metabolomics
Application summary
Rationale: Skeletal muscles play critical roles in locomotion and metabolism. Over the past 10 years, with support from the NSERC, I established a leading-edge program on autophagy (degradation and recycling of cellular components) in skeletal muscles. In this proposal, I will identify novel long non-coding RNAs (lncRNAs) that regulate skeletal muscle mass and function. LncRNAs (>200 nucleotides in length) are abundant, exert their functions through various mechanisms, and are implicated in many cellular processes. Little is known, however, about their roles in skeletal muscles. This project will identify lncRNAs and the molecular networks that regulate muscle homeostasis. To identify lncRNAs that regulate muscle atrophy, we performed pilot experiments in which adult mice were subjected to 24h of acute starvation or 7 days of hindlimb denervation. Transcriptome analyses of limb muscles revealed that only four upregulated (Gm16041, Gm45805, Gm15179, lnc-Trim63) and two downregulated (Gm3331, Gm28505) lncRNAs were consistently observed in both models of atrophy. In the next five years, I will identify the roles of these novel lncRNAs in the regulation of skeletal muscle homeostasis by achieving the following objectives:
Objective 1: To identify cellular and intracellular localization of lncRNAs in skeletal muscles. The six targeted lncRNAs will be detected by fluorescence in-situ hybridization and isolation of nuclear and cytoplasmic fractions of human and mouse skeletal muscles. Additionally, single muscle fibres will be isolated from mouse limb muscles and will be subjected to qPCR detection of lncRNAs.
Objective 2: To identify the roles of lncRNAs in skeletal muscle survival, proliferation, and differentiation. Gain-of- (overexpression) and loss-of-function (knockdown with GampeRs) approaches will be used to assess the roles of the six targeted lncRNA in the regulation of survival, proliferation, and differentiation of myoblasts (muscle progenitor cells) derived from humans and mice.
Objective 3: To identify the regulatory roles of lncRNAs in skeletal muscle and mass and function. Gain-of-function (overexpression) and loss-of-function (knockdown) of the six targeted lncRNAs in skeletal muscles of adult mice will be achieved by injecting adeno-associated viruses expressing full-length lncRNAs (overexpression) or anti-sense oligos (GapmeRs, knockdown) into limb muscles. Mice will be examined 4, 6, and 12 weeks later and muscles will be excised and examined for fibre size and type, mitochondrial function, proteolysis, and contractility using established assays.
Objective 4: To identify molecular mechanisms through which lncRNAs regulate skeletal muscle mass. Bulk RNA-Seq and metabolomic analyses will be performed on muscle samples in which the lncRNAs have been overexpressed or downregulated, as in Objective 3. Additionally, protein partners of a given lncRNA will be identified by RNA-pull down assays and mass spectrometry.